TOMI Environmental Solutions receives fourth order for SteraMist system

FREDERICK, Md. - TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ), a $20 million market cap company showing strong revenue growth of 19% in the last twelve months, has secured its fourth order for the recently launched SteraMist Integration System (SIS) platform, according to a press release statement issued Monday.

The order, placed by ARES Distribution, a global distributor of scientific and medical equipment, is for a biomedical research university in Coral Gables, Florida. Delivery is expected by late 2025.

"Securing this order is a testament to our commitment to innovation and collaboration within the sterilization technology space," said Elissa J. Shane, Chief Operating Officer of TOMI Environmental Solutions.

TOMI’s SteraMist technology utilizes a low percentage hydrogen peroxide as its active ingredient and employs patented ionized Hydrogen Peroxide technology for disinfection and decontamination purposes.

The company’s products are designed for various environments including hospitals, biosafety labs, pharmaceutical facilities, commercial buildings, schools, and food processing facilities.

TOMI Environmental Solutions specializes in disinfection and decontamination solutions. Its Binary Ionization Technology platform was originally developed under a defense grant in association with the Defense Advanced Research Projects Agency of the U.S. Department of Defense.

The company’s stock is traded on the Nasdaq under the ticker symbol TOMZ.

In other recent news, TOMI Environmental Solutions reported a year-over-year increase in net revenue for the first quarter of 2025, reaching approximately $1.6 million, up from $1.1 million in the same period last year. The company’s gross margin for the quarter was 60.4%, slightly below the average of 61.0% from the first three quarters of 2024. Additionally, TOMI successfully reduced its total operating expenses to about $1.7 million, down from $1.9 million in the first quarter of 2024. In another development, TOMI completed its first installation of the SteraMist Integration System Standalone in the pharmaceutical isolator market, working with a leading Contract Development and Manufacturing Organization. The company’s SteraMist technology also showed effectiveness against the Deformed Wing Virus, a significant threat to honeybee populations, as confirmed by a study from the U.S. Department of Agriculture. TOMI further announced the appointment of David Vanston as its new Chief Financial Officer, bringing over 25 years of financial leadership experience. Lastly, H.C. Wainwright analyst Amit Dayal maintained a Buy rating on TOMI Environmental Solutions, with a price target of $3.50, following the recent financial results.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.